Cover Image

Contact precautions for MRSA and VRE: where are we now? A survey of the Society for Healthcare Epidemiology of America Research Network

Abstract Objective: Contact precautions for methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE) have limited data on efficacy and have been associated with patient harm. Still, a 2015 Society for Healthcare Epidemiology of America (SHEA) Research Network (S...

Full description

Saved in:

Bibliographic Details
Main Authors:	Elise Martin (Author), Daniel J. Morgan (Author), Rachel Pryor (Author), Gonzalo Bearman (Author)
Format:	Book
Published:	Cambridge University Press, 2024-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Where are we now and where are we headed?
by: Ewan A. Langan
Published: (2023)

Timesavers: Clinical Decision Support and Automation of MRSA and VRE Deisolation
by: Molly Paras, et al.
Published: (2024)

Impact of discontinuation of contact precautions on surveillance- and whole-genome sequencing-defined MRSA infections
by: Sharon Karunakaran, et al.
Published: (2023)

Contact precautions for the control of endemic pathogens: Finding the middle path
by: Gonzalo M. Bearman, et al.
Published: (2023)

Cannabinoids in Periodontology: Where Are We Now?
by: Yésica Carmona Rendón, et al.
Published: (2023)

Osteochondral techniques: where are we now?
by: Giovanna Medina, et al.
Published: (2023)

Diversity and persistence of MRSA and VRE in nursing homes: Environmental screening and whole-genome sequencing
by: Marco Cassone, et al.
Published: (2022)

Resistant Hypertension: Where are We Now and Where Do We Go from Here?
by: Pathan MK, et al.
Published: (2020)

Synergies for Better Learning - Where Are We Now?
by: Morten Søby
Published: (2013)

Born too Early, Where are We Now?
by: Hermanto T Joewono
Published: (2018)

Fat and bone in children - where are we now?
by: Paul Dimitri
Published: (2018)

Neonatal sepsis biomarkers: where are we now?
by: Gilfillan M, et al.
Published: (2019)

Tigecycline Containing Polymethylmethacrylate Cement Against MRSA, VRE, and ESBL-In Vitro Mechanical and Microbiological Investigations
by: Michael Abramowicz, et al.
Published: (2024)

Editorial: Neonatal ECMO in 2019: Where Are We Now? Where Next?
by: Giacomo Cavallaro, et al.
Published: (2022)

Active surveillance and contact precautions for preventing MRSA healthcare-associated infections during the COVID-19 pandemic
by: Brian McCauley, et al.
Published: (2023)

Noninvasive prenatal testing of aneuploidies: where are we now?
by: Aleksandra Jezela-Stanek, et al.
Published: (2014)

Anticytokine therapy for periodontal diseases: Where are we now?
by: Waykole Yogesh, et al.
Published: (2009)

Medical-Dental Integration in Medicare: Where are We Now?
by: Lisa Simon, et al.
Published: (2023)

Artemisinin resistance and malaria elimination: Where are we now?
by: Borimas Hanboonkunupakarn, et al.
Published: (2022)

Editorial: Antipsychotics of New Generation: Where Are We now?
by: Tatiana V. Lipina, et al.
Published: (2021)

Neuropsychiatric systemic lupus erythematosus: where are we now?
by: M. Padovan, et al.
Published: (2011)

Where Are We Now with the Implementation of the Talent Development Framework for Gifted Students and Where Do We Go in the Future?
by: Paula Olszewski-Kubilius
Published: (2024)

Peripheral Markers of Immune Response in Major Psychiatric Disorders: Where Are We Now and Where Do We Want to Be?
Published: (2019)

Cyberbullying: Where Are We Now? A Cross-National Understanding
by: Conor Mc Guckin (Ed.)
Published: (2017)

Medical education and post pandemic challenges: where are we now?
by: Valeria Vásquez Estrada, et al.
Published: (2023)

Human Papillomavirus Vaccine for Cervical Cancer: Where are we Now?
by: Horng-Jyh Tsai, MD, FACOG
Published: (2005)

Human Papillomavirus Vaccine for Cervical Cancer: Where Are We Now?
by: Wen-Fang Cheng
Published: (2005)

Oral microbiome and peri-implant diseases: where are we now?
by: Pokrowiecki R, et al.
Published: (2017)

International workshop on "professionalism in the practice of medicine- where are we now?"
by: Ora Paltiel, et al.
Published: (2017)

Adjuvant treatment for high risk melanoma. Where are we now?
by: Anand Sharma, et al.
Published: (2011)

Adjuvant treatment for high risk melanoma. Where are we now?
by: Anand Sharma, et al.
Published: (2011)

Application of Artificial Intelligence in Capsule Endoscopy: Where Are We Now?
by: Youngbae Hwang, et al.
Published: (2018)

A Hundred Years of Diagnosing Superficial Fungal Infections: Where Do We Come From, Where Are We Now and Where Would We Like To Go?
by: Yvonne Gräser, et al.
Published: (2020)

The control of Hyalomma ticks, vectors of the Crimean-Congo hemorrhagic fever virus: Where are we now and where are we going?
by: Sarah I Bonnet, et al.
Published: (2022)

Interleukin-1 Blockade in Polygenic Autoinflammatory Disorders: Where Are We now?
by: Hana Malcova, et al.
Published: (2021)

Oxygen in the neonatal ICU: a complicated history and where are we now?
by: Rachna R. Mamidi, et al.
Published: (2024)

Capecitabine versus 5-fluorouracil in colorectal cancer: where are we now?
by: Lakshmi Chintala, et al.
Published: (2011)

Where Are We Now with Oncolytic Viruses in Melanoma and Nonmelanoma Skin Malignancies?
by: George Nassief, et al.
Published: (2024)

Hyaluronic Acid-Based Nanomaterials Applied to Cancer: Where Are We Now?
by: Vera Machado, et al.
Published: (2022)

Application of Botulinum Neurotoxin in Lower Urinary Tract Dysfunctions: Where Are We Now?
Published: (2023)